SCHEMBL13746782

SCHEMBL13746782

CN(C)C(=O)Oc1ccc(F)cc1/C=C1\SC(N2CCN(CCO)CC2)=NC1=O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 1/20 0.57
▸ CCR5 P51681 1/20 0.57
▸ NPC1 O15118 3/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ POLB P06746 1/20 0.43
▸ GRIN1 Q05586 3/20 0.42
▸ GRIN2B Q13224 3/20 0.42
▸ AMY1A P0DUB6 1/20 0.42
▸ ENPP2 Q13822 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13747830 0.94 ACKR3 (0.56) ACKR3CCR5NPC1MCHR1MEN1
SCHEMBL13746970 0.88 ACKR3 (0.55) ACKR3CCR5NPC1MCHR1MEN1
SCHEMBL13747197 0.86 ACKR3 (0.50) ACKR3CCR5NPC1MCHR1MEN1
SCHEMBL13616320 0.82 ACKR3 (0.57) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL3431124 0.81 GRIN1 (0.60) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL3431127 0.81 GRIN1 (0.60) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL13746729 0.80 ACKR3 (0.49) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL3428172 0.80 ACKR3 (0.49) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL3428171 0.80 ACKR3 (0.49) ACKR3CCR5NPC1MEN1KMT2A
SCHEMBL13630619 0.80 MEN1 (0.45) NPC1MEN1KMT2APOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009097695-A1 ARYLMETHYLIDENE HETEROCYCLES AS NOVEL ANALGESICS CHLORION PHARMA, INC. (CA) 2009-08-13 — — WO disclosed
Send feedback